Current Treatment of Locoregional Recurrence of Melanoma

被引:0
|
作者
Malcolm Hart Squires
Keith A. Delman
机构
[1] Emory University,Department of Surgery, Division of Surgical Oncology, Winship Cancer Institute
来源
Current Oncology Reports | 2013年 / 15卷
关键词
Melanoma; Recurrence; Locoregional; Isolated limb perfusion; Isolated limb infusion; Electrochemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
Surgical resection is the mainstay of therapy for locoregional recurrence of melanoma and the best chance for long-term cure in patients with locoregional recurrence of melanoma. In addition to true local recurrence at the site of the primary lesion, locoregional relapse can occur as regional nodal disease or as satellite or in-transit metastases, which may be unresectable and can present significant treatment challenges. Options for unresectable locoregional recurrence include regional hyperthermic isolated limb perfusion or isolated limb infusion, topical therapies, intralesional injection therapies, laser ablation, radiation therapy, and systemic therapy. Given the risk of further relapse and the negative impact on prognosis and overall survival after locoregional recurrence of melanoma, most patients should be considered for aggressive locoregional therapy.
引用
收藏
页码:465 / 472
页数:7
相关论文
共 50 条
  • [31] Serum microRNAs as biomarkers for recurrence in melanoma
    Erica B Friedman
    Shulian Shang
    Eleazar Vega-Saenz de Miera
    Jacob Ulrik Fog
    Maria Wrang Teilum
    Michelle W Ma
    Russell S Berman
    Richard L Shapiro
    Anna C Pavlick
    Eva Hernando
    Adam Baker
    Yongzhao Shao
    Iman Osman
    Journal of Translational Medicine, 10
  • [32] Breast Cancer Multifocality and Multicentricity and Locoregional Recurrence
    Lynch, Siobhan P.
    Lei, Xiudong
    Hsu, Limin
    Meric-Bernstam, Funda
    Buchholz, Thomas A.
    Zhang, Hong
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana M.
    Valero, Vicente
    ONCOLOGIST, 2013, 18 (11) : 1167 - 1173
  • [33] BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy
    Sloot, Sarah
    Zager, Jonathan S.
    Kudchadkar, Ragini R.
    Messina, Jane L.
    Benedict, Jacob J.
    Gonzalez, Ricardo J.
    DeConti, Ronald
    Turner, Leslie M.
    McCardle, Timothy
    Smalley, Keiran S. M.
    Weber, Jeffrey S.
    Sondak, Vernon K.
    Gibney, Geoffrey T.
    MELANOMA RESEARCH, 2016, 26 (01) : 83 - 87
  • [34] Locoregional Spread of Cutaneous Melanoma: Sonography Findings
    Catalano, Orlando
    Caraco, Corrado
    Mozzillo, Nicola
    Siani, Alfredo
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (03) : 735 - 745
  • [35] Locoregional Lymphadenectomy in the Surgical Management of Anorectal Melanoma
    Daniel R. Perez
    Atthaphorn Trakarnsanga
    Jinru Shia
    Garrett M. Nash
    Larissa K. Temple
    Philip B. Paty
    Jose G. Guillem
    Julio Garcia-Aguilar
    Danielle Bello
    Charlotte Ariyan
    Richard D. Carvajal
    Martin R. Weiser
    Annals of Surgical Oncology, 2013, 20 : 2339 - 2344
  • [36] Factors associated with locoregional recurrence in penile cancer: a case-control study
    Zarate-Gonzalez, Aldo
    Priego-Nino, Alejandro
    Salgado-Arroy, Victor
    Fernandez-Vivar, Elieser
    Montiel-Jarquin, Alvaro
    CIRUGIA Y CIRUJANOS, 2021, 89 (06): : 792 - 796
  • [37] Current Molecular Markers of Melanoma and Treatment Targets
    Yang, Kevin
    Oak, Allen S. W.
    Slominski, Radomir M.
    Brozyna, Anna A.
    Slominski, Andrzej T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [38] Current state of treatment for primary cutaneous melanoma
    E. S. Chung
    M. S. Sabel
    V. K. Sondak
    Clinical and Experimental Medicine, 2004, 4 : 65 - 77
  • [39] Current status of gene therapy in melanoma treatment
    Wang, Yonglu
    You, Wei
    Li, Xueming
    BIOCELL, 2020, 44 (02) : 167 - 174
  • [40] A Review of Current and Pipeline Drugs for Treatment of Melanoma
    Natarelli, Nicole
    Aleman, Sarah J.
    Mark, Isabella M.
    Tran, Jasmine T.
    Kwak, Sean
    Botto, Elizabeth
    Aflatooni, Shaliz
    Diaz, Michael J.
    Lipner, Shari R.
    PHARMACEUTICALS, 2024, 17 (02)